PoC Platform & Technology Market - by Technology (Lateral Flow Based Assays, Enzyme Label, Microfluidics, Biochips, Biosensors, and Others), by Application (Diagnostic and Monitoring, and Drug Development and Quality Testing), by End User (Hospitals, Clinics, Laboratories, Home Care Settings, and Others), and by Region - Global Industry Insights, and Forecast till 2025

  • Published On : Apr 2018 |
  • Pages : 210 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

POC Platform & Technology Market – Early Detection, Proactive Intervention

The point-of-care platforms and technologies have significantly contributed to the transformation of healthcare landscape by bringing rapid diagnosis and monitoring tests closer, and making it more convenient for healthcare providers and patients. The test results obtained by electronic health records (EHR) assists in quicker diagnosis leading to faster decision making and early treatment onset. The POC tests and devices help alleviate various pain points of hospital-based healthcare providers who are under constant pressure for delivering cost and time efficient care that enhances treatment outcomes of patients. These rapid POC tests address the issues of latency in test results by facilitating accurate evidence-based triage and diagnostic decisions within fraction of time when compared to the time taken by centralized laboratory tests.

The global POC platform & technology market was valued at US$ 21,370.3 Million in 2016 and is expected to exhibit a robust CAGR of 8.9% over the forecast period (2017 – 2025).

Figure 1. Global POC Platform & Technology Market Value (US$ Mn), by Region, 2016

poc platform technology market

Source: Coherent Market Insights (2018)

Increasing incidence of infectious and chronic diseases is expected to propel growth of the market

POC devices allow medical professionals to make decisions in patient’s vicinity, which results in significant healthcare delivery with faster results and immediate clinical management. The novel point-of-care tests (POCTs) offer diagnostic techniques for the prevention and treatment of infectious diseases such as HIV, Hepatitis B Virus, and chronic diseases such as diabetes, cancer, and cardiovascular disorders. According to the International Journal of Nanomedicine, in 2017, around 36.7 million people were affected by Human Immunodeficiency Virus (HIV) and around 400 million people were affected by viral hepatitis across the globe. The survey also stated that with no reliable treatment for HIV infection, early diagnosis is a critical factor in managing AIDS patients, as it is a major cause for morbidity and mortality globally. Furthermore, the point-of-care technologies have enabled efficient monitoring of heart rate, inflammation threats, and heart failure that can potentially avert complications, reduce economic burden, and improve patient care across diverse medical and home care settings. According to the American Heart Association, cardiovascular diseases account for 17.3 million deaths per year globally and by 2030, around 23.3 million people are expected to die from CVD.

Increasing cancer and diabetes incidences is one of the major factors driving demand for point of care diagnostic tools and assays. Monitoring of glucose, hemoglobin, ketones, and other factors allows prevention and early detection of diabetes-related acute and chronic complications, and has a positive impact on the process of care and management of patients with diabetes. According to National Cancer Institute, in 2016, around 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the same disease. The number of people suffering from cancer is expected to rise to 19 million by 2024. According to the Global Diabetes Community, in 2017, around 422 million adults suffer from diabetes globally, where the number is expected to escalate to 642 million by 2040.

Minimal requirement of technical expertise and portability offered by the novel point-of-care testing devices to accelerate the market growth

The increasing shortage of skilled healthcare workers is leading to demand for accurate, intuitive tests that can be operated by less skilled professionals and patients using home based devices for better patient outcomes. According to the World Health Organization (WHO), the global healthcare sector was facing a shortage of 7.2 million healthcare personnel in 2013 and is expected to face a shortage of 12.9 million by 2035, specializing in various sectors. Portability is one of the major factors facilitated by the recent point-of-care testing devices, wherein these devices offers the same results in less time making it more hassle free and feasible for the operators to use them. The reduction in size of these testing devices and assays makes them ideal for use in ambulance services as well as on patient’s bed side. Furthermore, easy operation and functioning of these devices is convenient for patients, as it can be used in their homes to measure their activities.

Major players operating in the global POC platform & technology market include Advanced Liquid Logic, Inc., Agilent Technologies, Axxicon Moulds Eindhoven B.V., Lifesensors, Inc., Abbott Laboratories, Siemens Healthineers, and LifeScan, Inc.

Point of care (PoC) diagnostic devices are used to obtain diagnostic results while being close to the patient and are commonly used in doctor’s office, hospitals, and in home care settings. These devices are commonly preferred in the home care settings, as they do not require technical expertise and deliver instant feedback on various medical tests. The vast applications of POC platform and technology devices include diagnosis of chronic diseases, drugs of abuse testing, and pregnancy. The benefits offered by the POC platform and technology systems include higher speed, portability, and convenience of diagnosis at the bedside of the patient. The point-of-care diagnostics are also finding its applications in medical imaging with the introduction of portable ultrasound devices that aids in imaging patients at places that are not easily accessible and provides insights about various medical conditions.

Market Dynamics

Increase in the prevalence of infectious diseases such as HIV, hepatitis, and vector borne diseases coupled with increasing awareness leading to early diagnosis of cancer and autoimmune diseases is a major factor propelling growth of POC platform & technology  market. Moreover, the increasing usage of home-based point-of-care diagnosis has also significantly reduced the incidence of sexually transmitted diseases (STDs), as these tests provide quick detection of biomarkers leading to early diagnosis of diseases. These diseases, if treated at early stages can extend the life expectancy and can also completely cure the patients in few cases. According to the Centers of Disease Control and Prevention (CDC), in 2016, rapid home-based diagnostic tests that include point-of-care immunoassay and test strips as well as general awareness have collectively resulted in reducing the number of annual infections caused due to HIV by 10% from 2010 to 2014 and by 5% from 2011 to 2015. The increasing R&D activities by the organizations also aids in market growth. For instance, the Bill & Melinda Gates Foundation supported the development of Alere Malaria Ag Plasmodium falciparum HRP2 ELISA.

Key features of the study:

  • This report provides in-depth analysis of POC platform & technology market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) over the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global POC platform & technology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Advanced Liquid Logic, Inc., Agilent Technologies, Axxicon Moulds Eindhoven B.V., Lifesensors, Inc., Abbott Laboratories, Siemens Healthineers, and LifeScan, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global POC platform & technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the POC platform & technology market

Detailed Segmentation:

  • Global POC Platform & Technology Market, By Technology:
    • Lateral Flow Based Assays
      • Colloidal Gold Label
      • Colored Latex Particle Label
      • Paramagnetic Monodisperse Latexes
      • Fluorescence Immunoassay
        • Traditional Fluorescence Immunoassay
        • Time Resolve Fluorescence Immunoassay
        • Upconverting Nanoparticles Immunoassay
        • Quantum Dot Immunoassay
    • Enzyme Labels
    • Microfluidics
    • Biochips
    • Biosensors
    • Medical MEMS
    • Agglutination
    • Solid Phase
    • Lab-on-a-chip
    • Chemiluminescence Based Systems
  • Global POC Platform & Technology Market, By Application:
    • Diagnostic and Monitoring
    • Drug Development and Quality Testing
  • Global POC Platform & Technology Market, By End User:
    • Hospitals
    • Clinics
    • Laboratories
    • Home Care Settings
    • Others
  • Global POC Platform & Technology Market, By Geography:
    • North America
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Lateral Flow Based Assays
          • Colloidal Gold Label
          • Colored Latex Particle Label
          • Paramagnetic Monodisperse Latexes
          • Fluorescence Immunoassay
            • Traditional Fluorescence Immunoassay
            • Time Resolve Fluorescence Immunoassay
            • Upconverting Nanoparticles Immunoassay
            • Quantum Dot Immunoassay
        • Enzyme Labels
        • Microfluidics
        • Biochips
        • Biosensors
        • Medical MEMS
        • Agglutination
        • Solid Phase
        • Lab-on-a-chip
        • Chemiluminescence Based Systems
      • By Application:
        • Diagnostic and Monitoring
        • Drug Development and Quality Testing
      • By End User:
        • Hospitals
        • Clinics
        • Laboratories
        • Home Care Settings
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Advanced Liquid Logic, Inc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Agilent Technologies
    • Axxicon Moulds Eindhoven B.V.
    • Lifesensors, Inc.
    • Abbott Laboratories
    • Siemens Healthineers
    • LifeScan, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Evolution of POC Diagnostics
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • Impacting Factors
    • Key Highlights
    • Benefits of POC Testing Systems
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Global and Regional Epidemiology
  4. Global POC Platform & Technology Market, By Technology, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Lateral Flow Based Assays
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
      • Segment Trends
        • Colloidal Gold Label
        • Colored Latex Particle Label
        • Paramagnetic Monodisperse Latexes
        • Fluorescence Immunoassay
          • Traditional Fluorescence Immunoassay
          • Time Resolve Fluorescence Immunoassay
          • Upconverting Nanoparticles Immunoassay
          • Quantum Dot Immunoassay
    • Enzyme Labels
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Microfluidics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Biochips
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Biosensors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Medical MEMS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Agglutination
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Solid Phase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Lab-on-a-chip
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Chemiluminescence Based Systems
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  5. Global POC Platform & Technology Market, By Application, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Diagnostic and Monitoring
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Drug Development and Quality Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  6. Global POC Platform & Technology Market, By End User, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2015 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
  7. Global POC Platform & Technology Market, By Region, 2015–2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016–2025
    • North America
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Technology, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Application, 2015–2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015–2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015–2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • Advanced Liquid Logic, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent Technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Axxicon Moulds Eindhoven B.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lifesensors, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Seimens Healthineers
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • LifeScan, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 46 market data tables and 38 figures on "POC Platform & Technology Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.